Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kolmar Korea Holdings Co., Ltd. (024720.KS)
KRW8,450.00
+200.00 (+2.42%)
KR KSC Consumer Defensive Household & Personal Products
Address
12-11 Doekgogae-gil
Sejong City, KR
Sejong City, KR
CEO
Sang-Hyun Yoon
Website
kolmar.co.kr
IPO
2000-02-11
ISIN KR7024720005
Also trades on
Korea Exchange · 024720.KS (KRW)
Korea Exchange · 161890.KS (KRW)
Description
Kolmar Korea Holdings Co., Ltd. is engaged in the manufacturing and global distribution of cosmetics, pharmaceutical products, and nutritional supplements, serving markets both within South Korea and internationally. Its comprehensive range of beauty offerings includes skincare, makeup, haircare, body care, and products designed for infants, alongside specialized functional cosmetics and fragrances. Furthermore, the company provides over-the-counter medications and dietary aids. Founded in 1990, its main corporate headquarters are situated in Sejong City, South Korea.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW8,450.00
+200.00 (+2.42%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
68.9K
Beta
0.81
Float Shares
17.68M
Free Float %
51.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.45% | -5.47% | -16.10% | -10.07% | -17.96% | -17.21% | -36.24% | +14.51% | -48.30% | -71.97% | +1,440.01% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
8,450.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.37
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
4 / 5
High
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Household & Personal Products: +3.3%-6.9% Q1'26: -0.3% (vs Q1'25)
-
EPS growth Household & Personal Products: +8.8%-3.5% Q1'26: +7,364.6% (vs Q1'25)
-
FCF margin FCF growth · Household & Personal Products: +44.8%-1.2% Q1'26: +3.7% (vs Q1'25)
-
EBIT margin Household & Personal Products: +9.9%+2.6% Q1'26: +6.1% (vs Q1'25)
-
ROIC Household & Personal Products: +8.2%+1.0% Q1'26: +2.8% (vs Q1'25)
-
Share dilution Household & Personal Products: +0.2%-1.1% ★ Q1'26: +43.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Household & Personal Products: -0.51×9.14× Q1'26: 5.75× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2014 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
|---|---|---|---|---|---|---|
| Revenue |
222.47B
est: 432.00B (-48.5%)
|
330.44B
est: 324.40B (+1.9%)
|
490.57B
est: 487.50B (+0.6%)
|
561.70B
est: 654.00B (-14.1%)
|
593.43B
est: 699.00B (-15.1%)
|
675.48B
est: 839.60B (-19.5%)
|
| EBITDA |
31.55B
est: 66.57B (-52.6%)
|
78.17B
est: 49.99B (+56.4%)
|
84.44B
est: 75.12B (+12.4%)
|
128.52B
est: 100.78B (+27.5%)
|
87.79B
est: 107.72B (-18.5%)
|
207.69B
est: 129.38B (+60.5%)
|
| EBIT |
36.97B
est: 53.64B (-31.1%)
|
73.06B
est: 40.28B (+81.4%)
|
77.52B
est: 60.53B (+28.1%)
|
120.71B
est: 81.21B (+48.6%)
|
75.56B
est: 86.80B (-12.9%)
|
189.82B
est: 104.25B (+82.1%)
|
| Net Income |
19.51B
est: 10.57B (+84.6%)
|
36.64B
est: 25.29B (+44.9%)
|
28.03B
est: 40.65B (-31.0%)
|
90.23B
est: 46.62B (+93.6%)
|
72.24B
est: 50.55B (+42.9%)
|
113.14B
est: 56.90B (+98.8%)
|
| SGA |
11.19B
est: 13.95B (-19.8%)
|
18.07B
est: 10.48B (+72.5%)
|
25.67B
est: 15.74B (+63.1%)
|
20.20B
est: 21.12B (-4.4%)
|
10.89B
est: 22.57B (-51.8%)
|
11.15B
est: 27.11B (-58.9%)
|
| EPS |
1,198.00
est: 304.71 (+293.2%)
|
2,201.00
est: 729.00 (+201.9%)
|
1,683.00
est: 1,172.00 (+43.6%)
|
4,563.43
est: 1,344.00 (+239.5%)
|
3,911.58
est: 1,457.50 (+168.4%)
|
3,061.50
est: 1,640.50 (+86.6%)
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-06-09 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-06-08 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-06-05 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-06-04 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-06-02 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-06-01 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-29 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-28 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-27 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 4/5 | 4/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 2/5 | 3/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 2/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 2/5 | 4/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
12.80B
OE per share TTM
373.58
Owner's Yield
3.15%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
44.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex KOSPI 226490.KS | 0.01% | 69.6K | 0.15% |
| 2 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 17.7K | 0.33% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
147.46M
Shares Outstanding
34.30M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sang-Hyun Yoon | Chief Executive Officer & Director | 2B | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 024720.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
